8
ionic molecules are believed to be essential for the efficient
6
His -tagged fusion protein. When expressed at 37 °C for 3
3h
attachment of the bacteria to host cells and play important
h with the induction of 0.1 mM IPTG (isopropyl-1-thio-â-
D-galactopyranoside), the majority of the recombinant aldo-
lase presented in cell lysate as a soluble form, and it can be
easily purified by an affinity column packed with Ni -NTA-
agarose (nickel-nitrilotriacetic acid-agarose) resin. In agree-
4
roles in the virulence of the pathogenic organisms. For
example, KDN (deoxyneuraminic acid or 2-keto-3-deoxy-
D-glycero-D-galacto-nonulosonic acid), one of three basic
2+
5
sialic acid forms, was first found in rainbow trout eggs. It
6
a
has recently been detected in the cell wall of Streptomyces
ment with previous reports, the recombinant aldolase can
tolerate a wide range of modifications (even bulky groups)
at various positions on the ManNAc substrate or mannose
and it has been used successfully in one-pot multiple-enzyme
systems for the efficient synthesis of CMP-sialic acid
3
i
sp. VKM Ac-2090 and strain Streptomyces sp. VKM
3
h
Ac-2124 as â2,4-linked KDN polymers branched with
1
Glcâ1,8-linked side chains. Using the combination of H and
1
3
C NMR as well as MALDI-TOF mass spectrometry
8
9
analyses, KDN-containing oligomers have also been found
as cell wall components of Streptomyces sp. MB-8. They
are tetrasaccharide components with two â-D-Galp-(1f9)-
D-KDN disaccharides linked through an R-D-KDN-(2f4)-
â-D-KDN linkage, with some of the galactose residues being
derivatives and sialosides.
On the basis of the extremely flexible substrate specificity
of the sialic acid aldolase, we hypothesize that the disac-
charide structure â-D-Galp-(1f9)-D-KDN observed in the
cell wall of Streptomyces sp. MB-8 (Figure 1) can be
synthesized by an aldolase-catalyzed reaction from pyruvate
and a simpler disaccharide â-D-Galp-(1f6)-D-Manp, in
which the Gal residue can be considered as a substituent
replacing the H atom in the 6-O-hydroxyl group of the
mannose.
3
g
3
-O-methylated (Figure 1).3g
To test our hypothesis, disaccharide â-D-Galp-(1f6)-D-
Manp 1 was synthesized using a conventional synthetic
approach (Scheme 2). Direct tritylation followed by acety-
Scheme 2. Synthesis of Disaccharide â-D-Galp-(1f6)-D-Manp
1
Figure 1. Tetrasaccharide components found in the cell wall of
Streptomyces sp. MB-8.3g
Sialic acid aldolase (EC 4.1.3.3.) catalyzes a reversible
condensation of pyruvate with D-N-acetylmannosamine
(
ManNAc) to form D-N-acetylneuraminic acid (Neu5Ac) with
6
the equilibrium favoring the aldol cleavage (Scheme 1).
Scheme 1. Reaction Catalyzed by Sialic Acid Aldolases
lation of mannose 210 afforded acetyl 2,3,4-tri-O-acetyl-6-
O-trityl-R-D-mannopyranoside 3 in 90% yield. Although it
(7) (a) Schauer, R.; Kamerling, J. P. In Glycoproteins II; Montreuil, J.,
Vliegenthart, J. F. G., Schachter, H., Eds.; Elsevier: Amsterdam, The
Netherlands, 1997; pp 243-402. (b) Gijsen, H. J. M.; Wong, C.-H. J. Am.
Chem. Soc. 1995, 117, 7585-7591. (c) Mahmoudian, M.; Noble, D.; Drake,
C. S.; Middleton, R. F.; Montgomery, D. S.; Piercey, J. E.; Ramlakhan,
D.; Todd, M.; Dawson, M. J. Enzyme Microb. Technol. 1997, 20, 393-
Sialic acid aldolase has flexible substrate specificity and has
been widely used in the enzymatic synthesis of naturally
occurring and structurally modified sialic acids.1a,7 We have
cloned a full-length sialic acid aldolase (NanA) from
Escherichia coli K-12 and overexpressed it as a C-terminal
400. (d) Kim, M. J.; Hennen, W. J.; Sweers, H. M.; Wong, C.-H. J. Am.
Chem. Soc. 1988, 110, 6481-6486. (e) Simon, E. S.; Bednarski, M. D.;
Whitesides, G. M. J. Am. Chem. Soc. 1988, 110, 7159-7163. (f) Kragl,
U.; Gygax, D.; Ghisalba, O.; Wandrey, C. Angew. Chem., Int. Ed. 1991,
30, 827-828. (g) Halcomb, R. L.; Fitz, W.; Wong, C. H. Tetrahedron:
Asymmetry 1994, 5, 2437-2442. (h) Kong, D. C. M.; von Itzstein, M.
Carbohydr. Res. 1997, 305, 323-329. (i) Lin, C. C.; Lin, C.-H.; Wong,
C.-H. Tetrahedron Lett. 1997, 38, 2649-2652. (j) Pan, Y.; Ayani, T.; Nadas,
J.; Wen, S.; Guo, Z. Carbohydr. Res. 2004, 339, 2091-2100. (k) Fitz, W.;
Schwark, J.-R.; Wong, C.-H. J. Org. Chem. 1995, 60, 3663-3670.
(8) Yu, H.; Yu, H.; Karpel, R.; Chen, X. Bioorg. Med. Chem. 2004, 12,
6427-6435.
(
4) Bardotti, A.; Averani, G.; Berti, F.; Berti, S.; Galli, C.; Giannini, S.;
Fabbri, B.; Proietti, D.; Ravenscroft, N.; Ricci, S. Vaccine 2005, 23, 1887-
899.
5) Nadano, D.; Iwasaki, M.; Endo, S.; Kitajima, K.; Inoue, S.; Inoue,
Y. J. Biol. Chem. 1986, 261, 11550-11557.
6) (a) Wong, C.-H. In Enzymes in Synthetic Organic Chemistry; Wong,
1
(
(
(9) Yu, H.; Chokhawala, H.; Karpel, R.; Yu, H.; Wu, B.; Zhang, J.;
Zhang, Y.; Jia, Q.; Chen, X. J. Am. Chem. Soc. 2005, 127, 17618-17619.
(10) Reynolds, D. D.; Evans, W. L. J. Am. Chem. Soc. 1940, 62, 66-
69.
C.-H., Whitesides, G. M., Eds.; Elsevier Science Ltd: Oxford, U.K., 1994;
pp 215-219. (b) Auge, C.; David, S.; Gautheron, C. Tetrahedron Lett. 1984,
2
5, 4663-4664.
2394
Org. Lett., Vol. 8, No. 11, 2006